3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
10
Lymphoma
5
Neoplasms, Germ Cell and Embryonal
3
Seminoma
2
Vulvar Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Neoplasms, Second Primary
1
Neoplasms
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Hemangioma, Capillary
1
Endodermal Sinus Tumor
1
Desmoid Tumors
1
Carcinoma, Embryonal
1
Interventions
pembrolizumab
137
Nivolumab
116
Ipilimumab
68
Cyclophosphamide
33
Specimen Handling
31
Magnetic Resonance Spectroscopy
28
trametinib
23
binimetinib
22
fludarabine
21
Interleukin-2
20
dabrafenib
19
relatlimab
17
encorafenib
17
Biopsy
17
CTLA-4 Antigen
16
cemiplimab
15
atezolizumab
15
aldesleukin
15
Radiosurgery
15
fludarabine phosphate
14
Opdualag
14
Radiotherapy
11
lenvatinib
10
Blood Specimen Collection
10
lifileucel
9
Paclitaxel
8
Cisplatin
8
Bevacizumab
8
spartalizumab
7
cobimetinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Bleomycin
×
1 year
×
Clear all
No trials found.